HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1619442Generated: October 27, 2026
5-(4-(6-(4-(2,2-Dimethyl-1,3-dioxan-5-yl)phenoxy)-5-methylpyrimidin-4-yloxy)piperidin-1-yl)-3-isopropyl-1,2,4-oxadiazole → 2-(4-(6-(1-(3-Isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yloxy)-5-methylpyrimidin-4-yloxy)phenyl)propane-1,3-diol
https://huagongshe.com/reaction/1619442
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 5-(4-(6-(4-(2,2-Dimethyl-1,3-dioxan-5-yl)phenoxy)-5-methylpyrimidin-4-yloxy)piperidin-1-yl)-3-isopropyl-1,2,4-oxadiazole | HCID 67515905 | — |
| Solvent | Acetone | HCID 180 | — |
| Product | 2-(4-(6-(1-(3-Isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yloxy)-5-methylpyrimidin-4-yloxy)phenyl)propane-1,3-diol | HCID 67515871 | 8.1% |
Reaction Steps
To a solution of 5-(4-(6-(4-(2,2-dimethyl-1,3-dioxan-5-yl)phenoxy)-5-methylpyrimidin-4-yloxy)piperidin-1-yl)-3-isopropyl-1,2,4-oxadiazole (500 mg, 0.0095 moles) in acetone (10 ml) conc. HCl (3 ml) was added portion-wise and reaction mixture was stirred for 2 hours at 27° C. The reaction mixture was concentrated and residue was dissolved in ethyl acetate. The organic extract was successively washed with water & brine, dried over sodium sulfate and evaporated under reduced pressure to yield 360 mg product as white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08772302B2 |
|---|
| Source dataset | uspto-grants-2014_07 |
|---|
| ORD ID | ord-3aa1c150ad544c7a841e600186157fa2 |
|---|
| Source note | uspto-grants-2014_07 |
|---|